FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2974917770> ?p ?o ?g. }

• W2974917770 abstract "To adequately ascertain drug safety and efficacy, drug trials need to include participants from all groups likely to receive the medication following approval. Pregnant women, however, are mostly excluded from trials, and women participating are often required to use highly effective contraception and taken off study product (even off study) if they conceive. There is little commercial incentive for including pregnant women in clinical trials, even when preclinical animal and human pharmacokinetic and safety data appear reassuring. With this conservative approach, large numbers of pregnant women are exposed to drug postlicensing with little known about drug safety and efficacy, and little done to systematically monitor outcomes of pregnancy exposure.The article focuses on antiretrovirals for treating and preventing HIV, and presents potential approaches which could extend to other therapeutic areas, to obtaining adequate and timely data to inform use of these drugs in this population. Most importantly the pregnancy risk profile of investigational agents can be systematically stratified from low to high risk, based on guidelines from regulatory bodies. This stratification can determine the progress through preclinical work with animals and non-pregnant women to opportunistic studies among women who become pregnant on a clinical trial or within routine clinical treatment. Stratification can include pregnant women in clinical trials, concurrent with Phase II/III trials in non-pregnant adults, and ultimately to postmarketing surveillance for outcomes in pregnant women and their infants. Each step can be enabled by clear criteria from international and local regulatory bodies on progression through study phases, standardized protocols for collecting relevant data, collaborative data sharing, pregnancy outcomes surveillance systems supported by committed funding for these endeavours.A formalized step-wise approach to including pregnant women in antiretroviral drug research should become the new norm. Systematic implementation of this approach would yield more timely and higher quality pregnancy dosing, safety and efficacy data. Through more vigorous action, regulatory bodies could responsibly overcome reluctance to include pregnant women in drug trials. Funders, researchers and programme implementers need to be galvanized to progressively include pregnant women in research - the use of newer, more effective drugs in women is at stake (349)." @default.
• W2974917770 created "2019-09-26" @default.
• W2974917770 creator A5000589233 @default.
• W2974917770 creator A5007876312 @default.
• W2974917770 creator A5017874022 @default.
• W2974917770 creator A5029221966 @default.
• W2974917770 creator A5032863083 @default.
• W2974917770 creator A5039442412 @default.
• W2974917770 creator A5041365930 @default.
• W2974917770 creator A5055076859 @default.
• W2974917770 creator A5058881734 @default.
• W2974917770 creator A5067097024 @default.
• W2974917770 creator A5080846431 @default.
• W2974917770 creator A5081855852 @default.
• W2974917770 creator A5090830881 @default.
• W2974917770 date "2019-09-01" @default.
• W2974917770 modified "2023-10-15" @default.
• W2974917770 title "Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?" @default.
• W2974917770 cites W1652164871 @default.
• W2974917770 cites W1774753613 @default.
• W2974917770 cites W1868158647 @default.
• W2974917770 cites W1884269062 @default.
• W2974917770 cites W1975974005 @default.
• W2974917770 cites W1976627773 @default.
• W2974917770 cites W1977000190 @default.
• W2974917770 cites W1982499526 @default.
• W2974917770 cites W1993680359 @default.
• W2974917770 cites W1995798071 @default.
• W2974917770 cites W1996065655 @default.
• W2974917770 cites W1999070611 @default.
• W2974917770 cites W2003321739 @default.
• W2974917770 cites W2003823538 @default.
• W2974917770 cites W2007309846 @default.
• W2974917770 cites W2008099140 @default.
• W2974917770 cites W2009515164 @default.
• W2974917770 cites W2011188155 @default.
• W2974917770 cites W2011572541 @default.
• W2974917770 cites W2019042796 @default.
• W2974917770 cites W2024474319 @default.
• W2974917770 cites W2029533867 @default.
• W2974917770 cites W2039105457 @default.
• W2974917770 cites W2042985334 @default.
• W2974917770 cites W2053201524 @default.
• W2974917770 cites W2055120595 @default.
• W2974917770 cites W2058627164 @default.
• W2974917770 cites W2060870465 @default.
• W2974917770 cites W2072104155 @default.
• W2974917770 cites W2075856485 @default.
• W2974917770 cites W2077012883 @default.
• W2974917770 cites W2089307259 @default.
• W2974917770 cites W2101205076 @default.
• W2974917770 cites W2104725842 @default.
• W2974917770 cites W2107720872 @default.
• W2974917770 cites W2120088007 @default.
• W2974917770 cites W2127721804 @default.
• W2974917770 cites W2134183368 @default.
• W2974917770 cites W2142839536 @default.
• W2974917770 cites W2146639626 @default.
• W2974917770 cites W2146986579 @default.
• W2974917770 cites W2152293167 @default.
• W2974917770 cites W2155050390 @default.
• W2974917770 cites W2162838101 @default.
• W2974917770 cites W2167984484 @default.
• W2974917770 cites W2294843139 @default.
• W2974917770 cites W2328779004 @default.
• W2974917770 cites W2401327147 @default.
• W2974917770 cites W2409581662 @default.
• W2974917770 cites W2418641901 @default.
• W2974917770 cites W2425436415 @default.
• W2974917770 cites W2474271066 @default.
• W2974917770 cites W2547697724 @default.
• W2974917770 cites W2548057917 @default.
• W2974917770 cites W2553355845 @default.
• W2974917770 cites W2560255567 @default.
• W2974917770 cites W2568934198 @default.
• W2974917770 cites W2592985839 @default.
• W2974917770 cites W2606421020 @default.
• W2974917770 cites W2613171419 @default.
• W2974917770 cites W2617659606 @default.
• W2974917770 cites W2620653718 @default.
• W2974917770 cites W2623786390 @default.
• W2974917770 cites W2738541296 @default.
• W2974917770 cites W2745285679 @default.
• W2974917770 cites W2771911682 @default.
• W2974917770 cites W2777129343 @default.
• W2974917770 cites W2786157050 @default.
• W2974917770 cites W2793487607 @default.
• W2974917770 cites W2884405141 @default.
• W2974917770 cites W2888034043 @default.
• W2974917770 cites W2899344433 @default.
• W2974917770 cites W2933955404 @default.
• W2974917770 cites W2974917770 @default.
• W2974917770 cites W3010330108 @default.
• W2974917770 cites W4230500325 @default.
• W2974917770 doi "https://doi.org/10.1002/jia2.25372" @default.
• W2974917770 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6747006" @default.
• W2974917770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31529598" @default.
• W2974917770 hasPublicationYear "2019" @default.
• W2974917770 type Work @default.
• W2974917770 sameAs 2974917770 @default.

• next